Estrogen, DNA damage and mutations - PubMed (original) (raw)
Review
Estrogen, DNA damage and mutations
D Roy et al. Mutat Res. 1999.
Abstract
Estrogen administration to rodents results in various types of DNA damage and ultimately leads to tumors in estrogen-responsive tissues. Yet these hormones have been classified as nonmutagenic, because they did not induce mutations in classical bacterial and mammalian mutation assays. In this review, we have discussed the induction by estrogens of DNA and chromosomal damage and of gene mutations, because the classical assays were designed to uncover mutations only at one specific locus and could not have detected other types of mutations or changes in other genes. Various types of estrogen-induced DNA damage include: (a) direct covalent binding of estrogen quinone metabolites to DNA; (b) enhancement of endogenous DNA adducts by chronic estrogen exposure of rodents; (c) free radical generation by metabolic redox cycling between quinone and hydroquinone forms of estrogens and free radical damage to DNA such as strand breakage, 8-hydroxylation of purine bases of DNA and lipid hydroperoxide-mediated DNA modification. Two different types of chromosomal damage have also been induced by estrogen in vivo and in cells in culture such as numerical chromosomal changes and also structural chromosomal aberrations. Gene mutations have been induced in several cell types in culture either by the parent estrogen or by reactive estrogen quinone metabolites. Furthermore, in estrogen-induced kidney tumors in hamsters, several mutations have been observed in the DNA polymerase beta gene mRNA. Estradiol also induces microsatellite instability in these kidney tumors and in premalignant kidney exposed to estradiol. Although this work is still ongoing, it can be concluded that estrogens are complete carcinogens capable of tumor initiation by mutation potentially in critical genes. The hormonal effects of estrogens may complete the development of tumors.
Copyright 1999 Elsevier Science B.V.
Similar articles
- Estrogens as endogenous genotoxic agents--DNA adducts and mutations.
Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D. Cavalieri E, et al. J Natl Cancer Inst Monogr. 2000;(27):75-93. doi: 10.1093/oxfordjournals.jncimonographs.a024247. J Natl Cancer Inst Monogr. 2000. PMID: 10963621 Review. - Genotoxic effects of estrogens.
Liehr JG. Liehr JG. Mutat Res. 1990 May;238(3):269-76. doi: 10.1016/0165-1110(90)90018-7. Mutat Res. 1990. PMID: 2160607 Review. - Neoplastic transformation of cultured mammalian cells by estrogens and estrogenlike chemicals.
Tsutsui T, Barrett JC. Tsutsui T, et al. Environ Health Perspect. 1997 Apr;105 Suppl 3(Suppl 3):619-24. doi: 10.1289/ehp.97105s3619. Environ Health Perspect. 1997. PMID: 9168005 Free PMC article. Review. - [Mechanisms of estrogen-induced carcinogenesis--detection of DNA adducts in cultured mammalian cells by 32P-postlabeling].
Tsutsui T. Tsutsui T. Nihon Yakurigaku Zasshi. 1997 Jul;110(1):1-9. doi: 10.1254/fpj.110.1. Nihon Yakurigaku Zasshi. 1997. PMID: 9285831 Review. Japanese.
Cited by
- Body composition and cancer survival: a narrative review.
Bradshaw PT. Bradshaw PT. Br J Cancer. 2024 Feb;130(2):176-183. doi: 10.1038/s41416-023-02470-0. Epub 2023 Oct 27. Br J Cancer. 2024. PMID: 37891197 Free PMC article. Review. - Vitamin C and alpha-naphthoflavone prevent estrogen-induced mammary tumors and decrease oxidative stress in female ACI rats.
Mense SM, Singh B, Remotti F, Liu X, Bhat HK. Mense SM, et al. Carcinogenesis. 2009 Jul;30(7):1202-8. doi: 10.1093/carcin/bgp093. Epub 2009 Apr 30. Carcinogenesis. 2009. PMID: 19406931 Free PMC article. - Variability in estrogen-metabolizing genes and their association with genomic instability in untreated breast cancer patients and healthy women.
dos Santos RA, Teixeira AC, Mayorano MB, Carrara HH, de Andrade J, Takahashi CS. dos Santos RA, et al. J Biomed Biotechnol. 2011;2011:571784. doi: 10.1155/2011/571784. Epub 2011 Jun 14. J Biomed Biotechnol. 2011. PMID: 21716904 Free PMC article. - A View on Uterine Leiomyoma Genesis through the Prism of Genetic, Epigenetic and Cellular Heterogeneity.
Koltsova AS, Efimova OA, Pendina AA. Koltsova AS, et al. Int J Mol Sci. 2023 Mar 17;24(6):5752. doi: 10.3390/ijms24065752. Int J Mol Sci. 2023. PMID: 36982825 Free PMC article. Review. - Crosstalk of Oncogenic Signaling Pathways during Epithelial-Mesenchymal Transition.
Lindsey S, Langhans SA. Lindsey S, et al. Front Oncol. 2014 Dec 11;4:358. doi: 10.3389/fonc.2014.00358. eCollection 2014. Front Oncol. 2014. PMID: 25566498 Free PMC article. Review.